ClinVar Miner

Submissions for variant NM_006005.3(WFS1):c.1525_1539del (p.Val509_Tyr513del)

dbSNP: rs781262017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001941578 SCV002233027 pathogenic not provided 2024-03-07 criteria provided, single submitter clinical testing This variant, c.1525_1539del, results in the deletion of 5 amino acid(s) of the WFS1 protein (p.Val509_Tyr513del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs781262017, gnomAD 0.01%). This variant has been observed in individual(s) with autosomal recessive Wolfram syndrome (PMID: 9771706, 25895475, 28432734). It has also been observed to segregate with disease in related individuals. This variant is also known as 1685del(CCTGCTCTATGTCTA) and del508YVYLL. ClinVar contains an entry for this variant (Variation ID: 1453842). For these reasons, this variant has been classified as Pathogenic.
GeneDx RCV001941578 SCV002559613 likely pathogenic not provided 2024-09-11 criteria provided, single submitter clinical testing In-frame deletion of 5 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23373429, 36098976, 9771706, 30352948, 33980734, 35452662, 35602877, 25895475, GosaliaH2023[Article], 28432734)
Fulgent Genetics, Fulgent Genetics RCV002507696 SCV002816225 pathogenic Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome 2022-04-26 criteria provided, single submitter clinical testing
Department Of Endocrinology, Sanjay Gandhi Postgraduate Institute Of Medical Sciences RCV002274237 SCV004025923 pathogenic Wolfram syndrome 1 2023-08-15 criteria provided, single submitter clinical testing Homozygous 15 base pair deletion in exon 8 of the WFS1 gene (chr4:g.6301320_6301334del) that results in the in-frame deletion of 5 amino acids. The observed variation has previously been reported in patients affected with Wolfram syndrome. This variant has not been reported in the 1000 genomes and gnomAD databases. The reference region is conserved across species. PS1, PM1, PM2, PM4, PP3.
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV003336476 SCV004046024 likely pathogenic Autosomal dominant nonsyndromic hearing loss 6 criteria provided, single submitter clinical testing This variant is also referred to as 1685del(CCTGCTCTATGTCTA) or 1683-1697del15 in the literature. This 15 base pair in-frame deletion is found in exon 8 of 8, and it leads to the loss of five amino acid residues. This variant has been previously reported as a homozygous (PMID: 23373429, 9771706, Gupta et al. 2018) and heterozygous change (PMID: 25895475) in individuals with WFS1-related disorders. The c.1525_1539del (p.Val509_Tyr513del) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.004% (10/249648) and thus is presumed to be rare. Based on the available evidence, the c.1525_1539del (p.Val509_Tyr513del) variant is classified as Likely Pathogenic.
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre RCV002274237 SCV005374459 pathogenic Wolfram syndrome 1 2024-09-22 criteria provided, single submitter clinical testing
OMIM RCV002274237 SCV000024942 pathogenic Wolfram syndrome 1 1998-10-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.